Clever Marketing Needed To Position J&J's New Psoriasis Drug Ahead Of Cheaper Options

 
• By Lucie Ellis-Taitt
  
Balloons
J&J's New Psoriasis Drug Will Have Stiff Competition If Approved On Back Of Strong PhIII Data • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Immunological

More from Therapeutic Category